PartneringPartnerships are an important component of our business plan. We have developed valuable alliances with world-class biotechnology and biopharmaceutical companies and have established research collaborations with distinguished academic investigators.
Teva Pharmaceutical
|
Initiated research collaboration to discover and develop a novel therapeutic antibody for Multiple Sclerosis (MS). Vaccinex continues development and has full ownership. |
GlaxoSmithKline
|
Vaccinex and EUSA Pharma licensed a fully human Vaccinex antibody to GSK. |
Biocon Limited
|
Co-development collaboration in which Biocon and Vaccinex jointly discover, develop and commercialize therapeutic antibody products. |
Bayer Schering Pharma
|
Collaboration to identify disease targets and potentially develop novel therapeutic antibodies for the treatment of cancer. | Please contact us to learn more.
1895 Mount Hope Avenue
Rochester, NY 14620
Phone: 585-271-2700
Fax: 585-271-2765
E-Mail: info@vaccinex.com |
1895 Mount Hope Avenue
Rochester, NY 14620
Phone: 585-271-2700
Fax: 585-271-2765
E-mail: busdev@vaccinex.com |
|